OTC Markets EXMKT - Delayed Quote USD

Innovation Pharmaceuticals Inc. (IPIX)

Compare
0.0001
0.0000
(0.00%)
At close: January 30 at 1:22:10 PM EST

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Leo Ehrlich CPA Chairman, CEO, CFO, Principal Accounting Officer & Secretary 515.85k -- 1958
Ms. Jane Harness M.S., MP Senior Vice President of Clinical Sciences & Portfolio Management 275k -- 1968
Mr. Jim Boeheim Business Advisor -- -- --

Innovation Pharmaceuticals Inc.

301 Edgewater Place
Suite 100
Wakefield, MA 01880
United States
978 921 4125 https://www.ipharminc.com
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
4

Description

Innovation Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective. Its lead drug candidate is Brilacidin, a therapeutic for the treatment of oral mucositis, inflammatory bowel disease, acute bacterial skin and skin structure infection, and COVID-19. The company has a license agreement with Alfasigma S.p.A.; and collaborative research agreement with Fox Chase Chemical Diversity Center, Inc. The company was formerly known as Cellceutix Corporation and changed its name to Innovation Pharmaceuticals Inc. in June 2017. Innovation Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Wakefield, Massachusetts.

Corporate Governance

Innovation Pharmaceuticals Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

November 22, 2024 at 9:00 PM UTC - December 6, 2024 at 9:00 PM UTC

Innovation Pharmaceuticals Inc. Earnings Date

Recent Events

February 1, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

December 5, 2023 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

November 20, 2023 at 12:00 AM UTC

10-Q: Periodic Financial Reports

November 15, 2023 at 12:00 AM UTC

NT 10-Q: Periodic Financial Reports

October 30, 2023 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 15, 2023 at 12:00 AM UTC

10-Q: Periodic Financial Reports

February 15, 2023 at 12:00 AM UTC

10-Q: Periodic Financial Reports

January 4, 2023 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

November 10, 2022 at 12:00 AM UTC

10-Q: Periodic Financial Reports

September 28, 2022 at 12:00 AM UTC

10-K: Periodic Financial Reports

Related Tickers

LOBEF Lobe Sciences Ltd.
0.0140
0.00%
 
BRAXF Braxia Scientific Corp.
0.0016
+6.67%
 
TCON TRACON Pharmaceuticals, Inc.
0.0322
0.00%
 
SVRA Savara Inc.
2.8000
+4.87%
 
SNPX Synaptogenix, Inc.
3.3500
-3.46%
 
SEELQ Seelos Therapeutics, Inc.
0.0030
+2,900.00%
 
LCTX Lineage Cell Therapeutics, Inc.
0.6265
+3.98%
 
TTNP Titan Pharmaceuticals, Inc.
3.4000
+3.66%
 
CBUS Cibus, Inc.
2.5500
+4.94%
 
ORGS Orgenesis Inc.
1.4400
+2.86%